Slide 1Flexible designs for pivotal clinical trials Vlad Dragalin, RSU-SDS-BDS-GSK FDA/Industry Workshop Session: Flexible Designs – Are We Ready Yet? Washington, D.C.,…

Slide 1The Role of Biotechnology and Bioinformatics in FDAs Critical Path Initiative Janet Woodcock M.D. Deputy Commissioner/Chief Medical Officer US Food and Drug Administration…

Slide 1THE ROLE OF ECVAM IN PROMOTING THE REGULATORY ACCEPTANCE OF ALTERNATIVE METHODS Dr Andrew Worth European Centre for the Validation of Alternative Methods (ECVAM) Institute…

Slide 1Regulatory Acceptance of Alternative Methods- Pharmaceuticals in the U.S. A. Jacobs 11/07 (not an official opinion) Slide 2 Overall ICCVAM OECD In vitro assays Flexibility…

Slide 1Environmental Laboratory Accreditation Course for Radiochemistry Presented by Minnesota Department of Health Pennsylvania Department of Environmental Protection U.S.…

Slide 1Army MMRP Site Inspections Performance-Based Contract Lessons Learned Gaby A. Atik, P.E. [email protected] FPM group August 2007 Slide 2 FPM group Outline PBC Background…

Slide 1MSW Conversion Technologies: Status in Summer 2012 Presented to the Board of Directors of the Municipal Review Committee, Inc. August 1, 2012 Slide 2 Status of MSW…

1.ConSoil 200810th Annual UFZ/TNO Conference on Soil-Water SystemsEU Critical Demonstration BestSamplingTriad Best Management and of MethodThePanel Design—Avoiding Pitfalls…

1. Flexible designs for pivotal clinical trials Vlad Dragalin, RSU-SDS-BDS-GSK FDA/Industry Workshop Session: Flexible Designs – Are We Ready Yet? Washington, D.C., September…

1. Sponsor and Provider Perceptions on Managing Clinical Development Risk ICR  Event   Enhancing  the  risk  based  approach  to  clinical  trials   2. 2 The Avoca…